Maitri Health Technologies Corp.
(MHTCF.PK) (MTEC.CN)

Get Top Rated Stock Alerts Active Traders Depend On

Sign Up Today For FREE News Driven Alerts

Former Johnson & Johnson Executive Joins Advisory Board at Maitri Health Technologies

Bridget Ross brings extensive experience in HealthTech development and services; Joins advisory board of healthcare, logistics, capital markets and innovation leaders

 

Vancouver, BC – March 23, 2021 – Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced the appointment of Bridget Ross to its Advisory Board.

 

Ms. Ross is currently CEO of ChroniSense Medical, Ltd., a U.S. HealthTech company and maker of wearable, medical-grade disease management devices. Over three decades, she held several executive roles at the world’s largest broadly based healthcare company, Johnson & Johnson (J&J), leading a number of medical divisions.

 

“Bridget brings an unmatched level of experience and success to Maitri’s extended team,” said Andrew Morton, CEO of Maitri. “Maitri is uniquely positioned to modernize healthcare systems for governments, healthcare systems and businesses to function well beyond the pandemic. Bridget’s counsel and insights on product development will be invaluable as we continue to evolve and execute our integrated PPE and technology strategy.”

 

Ms. Ross was previously President of the Global Medical Group at Henry Schein, where she led the growth strategy for a US$2.4 billion global business. At J&J, she was appointed Vice President, Commercial Operations of its Medical Device Sector, after previous roles as Global President at two J&J subsidiaries, leading product innovation and sales.

 

A graduate of the University of Alberta, Ms. Ross also previously served as a Health Sector Advisory Council Member at Duke University in North Carolina.  She joins a Maitri Advisory Board that includes a former Canadian Minister of Health, a former chief digital office of Bayer Inc., one of the world’s foremost specialists in infectious diseases and an internationally recognized expert in healthcare supply systems.

 

About Maitri Health Technologies

 

Maitri Health Technologies Corp. (CSE:MTEC) is a global platform for healthcare supply security. Our mission is to enhance safety and quality of life, and keep organizations and economies running. Maitri provides a reliable source of innovative, certified personal protective equipment (PPE) and testing solutions through an onshore manufacturing model. Our stable, scalable supply chain is integrated with unique digital technology to deliver a comprehensive healthcare supply platform. For more information: https://maitrihealth.ca/

 

For more information: investors@maitrihealth.ca

On behalf of the board of directors,

MAITRI HEALTH TECHNOLOGIES CORP.

Andrew Morton, Chief Executive Officer

 

Forward-Looking Statements

 

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking.  Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties.  We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

 

SOURCE: Maitri Health Technologies Corp.

Maitri Health Technologies Announces Health Canada Approval of Domestically Manufactured N95 Masks

Medical-grade protective gear designed and made in Canada; Offers greater certainty regarding source, quality and timely delivery of genuine N95 masks.

 

Vancouver, BC – March 17, 2021 – Maitri Health Technologies Corp. (OTCPK: MHTCF) (CSE: MTEC) (FRA: D84) (“Maitri”), a global platform for healthcare supply security, today announced the availability of N95 medical-grade protective masks, one of the few, domestically manufactured N95 masks to receive Health Canada certification.

 

N95 masks are among the most in-demand and difficult to source pieces of personal protective equipment (PPE) commonly used by hospital, healthcare and other frontline workers. N95 masks filter out at least 95 per cent of very small particles, including airborne droplets.

 

Maitri’s N95 masks, manufactured in Port Coquitlam, B.C. through an exclusive partnership with INNO Lifecare, were approved by Health Canada in March.

 

“Maitri is delivering what governments and organizations across Canada have sorely needed and requested since the beginning of the pandemic – a domestically manufactured and certified N95 mask,” said Andrew Morton, CEO of Maitri.

 

“Only a handful of Canadian companies have been approved to build and sell N95 masks here and we’ve immediately added this lifesaving PPE to our healthcare security platform.”

 

Demand for N95 masks has exceeded the supply globally and in Canada news reports have highlighted how healthcare workers and businesses were shortchanged on international orders, or worse, shipped counterfeit or uncertified N95 masks that put people at greater risk of exposure and illness.

 

Maitri’s N95 masks are a form-cut, cup mask that provides a tight seal to the face yet is comfortable to wear.

 

“Medical personnel and frontline workers will remain in harm’s way for the foreseeable future, for the current and other healthcare crises,” said Morton. “We also expect ongoing demand from healthcare facilities, factories and workplaces where personal safety remains the top priority. By supplying domestically manufactured N95 masks, we can offer Canadian governments and businesses peace of mind about the source, quality and timely delivery of critical PPE.”

 

N95 masks join certified surgical masks, face shields, disinfectants and sanitizers that make up Maitri’s comprehensive suite of PPE. Maitri’s unique healthcare supply security platform combines PPE with an integrated, seamless digital solution. Maitri helps organizations manage and monitor PPE and people by tracking vaccinations, activities, inventories and more – all with the goal of keeping people safer and businesses and economies running.

 

About Maitri Health Technologies

 

Maitri Health Technologies Corp. (CSE:MTEC) (FRA: D84) is a global platform for healthcare supply security. Our mission is to enhance safety and quality of life, and keep organizations and economies running. Maitri provides a reliable source of innovative, certified personal protective equipment (PPE) and testing solutions through an onshore manufacturing model. Our stable, scalable supply chain is integrated with unique digital technology to deliver a comprehensive healthcare supply platform. For more information: https://maitrihealth.ca/

 

For more information: investors@maitrihealth.ca

 

On behalf of the board of directors,

MAITRI HEALTH TECHNOLOGIES CORP.

Andrew Morton, Chief Executive Officer

 

Forward-Looking Statements

 

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking.  Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties.  We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

 

SOURCE:  Maitri Health Technologies Corp.

Maitri Health Technologies Adds Highly Sensitive, Accurate COVID-19 PCR Test to Healthcare Equipment Offering

Partners with industry leader DiaCarta to distribute QuantiVirus™ SARS-CoV-2 Test Kit;
In Canada and Mexico

 

Vancouver, BC –  January 19, 2021 – Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced it has signed a distribution agreement to offer a highly sensitive and accurate COVID-19 polymerase chain reaction (“PCR”) test as part of its comprehensive offering of personal protective equipment (“PPE”) and technology.

 

Maitri has partnered with DiaCarta, Inc. (“DiaCarta”), a California -based precision molecular diagnostics company with a global reputation in genomics and oncology testing. DiaCarta leveraged its diagnostic expertise to develop QuantiVirus, now certified in multiple countries and continents around the world.

 

In a recent report on US FDA, EUA approved tests the DiaCarta PCR test kits were ranked among the most effective (1) . “The high quality and sensitivity of the DiaCarta’s PCR test kits, which are verified by third-party clinical evaluations, is what attracted us to them,” said Andrew Morton , CEO. “Companies and healthcare officials can better protect their employees and communities if they have timely, accurate visibility about who has COVID-19 virus. The QuantiVirus test kits are easy to administer and the results are available in hours, not days, with commonly available lab equipment. We’ve come to learn that testing is critical for businesses and communities to help keep their people safer and healthier.”

 

Maitri’s partnership with DiaCarta includes an international distribution agreement, currently in Mexico and Canada . With US FDA, EUA and Mexican Cofepris authorizations in place, DiaCarta is currently under evaluation with Health Canada for approval.

 

The COVID-19 PCR test kits join Maitri’s extensive suite of PPE. 3D masks, patent-pending face shields, sanitizers and disinfectants – all integrated and supported by technology for improved tracking and tracing – help provide safer, more protected workplaces and communities.

 

(1)

GenomeWeb, “FDA Publishes First Batch of SARS-CoV-2 MDx Limit of Detection Comparison Results”, https://www.genomeweb.com/pcr/fda-publishes-first-batch-sars-cov-2-mdx-limit-detection-comparison-results#.YAZ40-hKhPY

 

About Maitri Health Technologies


Maitri Health Technologies Corp. (CSE: MTEC, FRA: D84) is a global platform for healthcare supply security. Our mission is to enhance safety and quality of life, and keep organizations and economies running. Maitri provides a reliable source of innovative, certified personal protective equipment and testing solutions through an onshore manufacturing model. Our stable, scalable supply chain is integrated with unique digital technology to deliver a comprehensive healthcare supply platform. For more information: https://maitrihealth.ca/

 

For more information: investors@maitrihealth.ca

 

Forward-Looking Statements

 

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

SOURCE Maitri Health Technologies Corp.

About Maitri Health Technologies


Current Pandemic has Exposed Fundamental Flaws in Global Supply Chains.

 

Recent experiences around the world have exposed the frailty of our global health care supply chains. Institutions, industry and governments are competing with each other to secure PPE, through questionable channels with little assurances for the reliability of the vendors or quality of products.

 

Healthcare has been faced with shortages and often forced to accept questionable materials. Industry has been put into an unprecedented situation where new safety protocols for workers has become essential to continue operations.

 

Created by industry leaders, Maitri Health is a coordinated, global platform that delivers reliable, high quality health care supplies with transparent supply chains and reasonable pricing.

 

By securing strategic partnerships and licensing agreements, we give our clients the confidence that medical supplies they receive are reliable and consistent. With advanced protocols for production, logistics and strict quality control, we ensure that our global community is prepared for every biomedical emergency.

 

Maitri Health is about purpose, quality, and reliability.

 

icons_01-Stroke

HIGHEST QUALITY + RELIABILITY

Domestically produced supplies that are compliant, reliable and easy to access.

 

 

 

icons_01-Outline

TRANSPARENT + COMPETITIVE PRICING

Long-term client-first values dictate our transparent and competitive pricing.

 

 

 

PPE

WORLD CLASS TEAM

Industry leaders in health, government, technology, capital markets, and high growth companies.

 

 

 

Maitri-Core_CoreComp-04-Sustainability

SUSTAINABLE + EVERGREEN SOLUTIONS

Focus on sustainable manufacturing and recycling practices.

 

 

Source:  https://maitrihealth.ca/

Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty nine hundred dollars for Maitri Health Technologies Corp. current news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF Maitri Health Technologies Corp.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Sign Up & Get FREE News Alerts From FNM Today!